Turtle Creek Wealth Advisors, LLC Astrazeneca PLC Transaction History
Turtle Creek Wealth Advisors, LLC
- $670 Billion
- Q1 2025
A detailed history of Turtle Creek Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Turtle Creek Wealth Advisors, LLC holds 43,787 shares of AZN stock, worth $2.98 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
43,787Holding current value
$2.98 Million% of portfolio
0.48%Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,418Shares Held
507MCall Options Held
8.14MPut Options Held
3.15M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.88 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.76 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.42 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.16 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.13 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...